NOVAVAX INC
8-K/A, EX-23.1, 2000-12-18
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: NOVAVAX INC, 8-K/A, 2000-12-18
Next: ATLANTIC TECHNOLOGY VENTURES INC, 424B3, 2000-12-18



<PAGE>   1

                                                                EXHIBIT 23.1


                       CONSENT OF INDEPENDENT ACCOUNTANTS




We hereby consent to the incorporation by reference in the Registration
Statements on Form S-3 (No. 333-22685, No. 333-77609 and No. 333-32142) and Form
S-8 (No. 333-77611 and No. 333-46000) of Novavax, Inc. of our report dated
October 20, 2000 relating to the combined financial statements of Fielding
Pharmaceutical Company and MB Packaging, Inc., which appears in the Current
Report on Form 8-K/A of Novavax, Inc. dated December 18, 2000.



PricewaterhouseCoopers LLP

McLean, Virginia
December 18, 2000


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission